Lipocine Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Salt Lake City, United States
LPCN chart
What traders are saying about $LPCN
Latest postsLipocine Inc. news
- PLEOPHARMA TO PRESENT SURVEY DATA ON CANNABIS WITHDRAWAL IN WOMEN SEEKING CANNABIS CESSATION PleoPharma, Inc. October 22
Yahoo Finance ·
- Lipocine Updates Investor Presentation to Reflect Strategy
The Globe and Mail ·
- Here's Why You Should Add LPCN Stock to Your Portfolio Now
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Lipocine Health Canada Approval Clears TLANDO for Canadian Testosterone Replacement Market
investorshub.advfn.com ·
- Lipocine stock surges 30% on Health Canada drug approval
Yahoo Finance ·
- LPCN Stock Is Surging: Here’s Why Lipocine Is On Traders’ Radar Today
stocktwits.com ·
- Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
Yahoo Finance ·
- Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo Finance ·
- Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
Yahoo Finance ·
- Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026
Yahoo Finance ·
Lipocine Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.0M | $11.2M | -$2.9M | $500,000 |
| Net income | -$9.6M | $10,000 | -$16.4M | -$10.8M |
| Diluted EPS | $-1.69 | – | $-3.14 | $-2.15 |
| Total assets (year end) | $17.0M | $22.5M | $23.0M | $37.5M |
| Cash and equivalents (year end) | $5.2M | $6.2M | $4.8M | $3.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lipocine Inc.
- Ticker
- LPCN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Salt Lake City, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1535955
- Former names
- MARATHON BAR CORP
Frequently asked questions
What exchange is Lipocine Inc. listed on?
Lipocine Inc. trades on the Nasdaq under the ticker symbol LPCN.
What industry is Lipocine Inc. in?
Lipocine Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lipocine Inc. headquartered?
Lipocine Inc.'s business address on file with the SEC is in Salt Lake City, United States.
When does Lipocine Inc.'s fiscal year end?
Lipocine Inc.'s fiscal year ends on December 31.
How much revenue did Lipocine Inc. report?
Lipocine Inc. reported $2.0M in revenue for calendar year 2025, according to its SEC filings.